Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Cox-2 Inhibitors market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Cox-2 Inhibitors market segmented into
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors
Based on the end-use, the global Cox-2 Inhibitors market classified into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on geography, the global Cox-2 Inhibitors market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL COX-2 INHIBITORS INDUSTRY
2.1 Summary about Cox-2 Inhibitors Industry
2.2 Cox-2 Inhibitors Market Trends
2.2.1 Cox-2 Inhibitors Production & Consumption Trends
2.2.2 Cox-2 Inhibitors Demand Structure Trends
2.3 Cox-2 Inhibitors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Selective Cox-2 Inhibitors
4.2.2 Non Selective Cox-2 Inhibitors
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Selective Cox-2 Inhibitors
5.2.2 Non Selective Cox-2 Inhibitors
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Selective Cox-2 Inhibitors
6.2.2 Non Selective Cox-2 Inhibitors
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Selective Cox-2 Inhibitors
7.2.2 Non Selective Cox-2 Inhibitors
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Selective Cox-2 Inhibitors
8.2.2 Non Selective Cox-2 Inhibitors
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Selective Cox-2 Inhibitors
9.2.2 Non Selective Cox-2 Inhibitors
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Retail Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bayer
10.1.2 Novartis
10.1.3 Pfizer
10.1.4 Merck
10.1.5 Cadila Pharmaceuticals
10.1.6 Sabinsa Corporation
10.2 Cox-2 Inhibitors Sales Date of Major Players (2017-2020e)
10.2.1 Bayer
10.2.2 Novartis
10.2.3 Pfizer
10.2.4 Merck
10.2.5 Cadila Pharmaceuticals
10.2.6 Sabinsa Corporation
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Cox-2 Inhibitors Product Type Overview
2.Table Cox-2 Inhibitors Product Type Market Share List
3.Table Cox-2 Inhibitors Product Type of Major Players
4.Table Brief Introduction of Bayer
5.Table Brief Introduction of Novartis
6.Table Brief Introduction of Pfizer
7.Table Brief Introduction of Merck
8.Table Brief Introduction of Cadila Pharmaceuticals
9.Table Brief Introduction of Sabinsa Corporation
10.Table Products & Services of Bayer
11.Table Products & Services of Novartis
12.Table Products & Services of Pfizer
13.Table Products & Services of Merck
14.Table Products & Services of Cadila Pharmaceuticals
15.Table Products & Services of Sabinsa Corporation
16.Table Market Distribution of Major Players
17.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
18.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
19.Table Global Cox-2 Inhibitors Market Forecast (Million USD) by Region 2021f-2026f
20.Table Global Cox-2 Inhibitors Market Forecast (Million USD) Share by Region 2021f-2026f
21.Table Global Cox-2 Inhibitors Market Forecast (Million USD) by Demand 2021f-2026f
22.Table Global Cox-2 Inhibitors Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Cox-2 Inhibitors Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Cox-2 Inhibitors Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Cox-2 Inhibitors Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Cox-2 Inhibitors Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Cox-2 Inhibitors Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Cox-2 Inhibitors Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Cox-2 Inhibitors Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Non Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Non Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Non Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Non Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Non Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Non Selective Cox-2 Inhibitors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Cox-2 Inhibitors Sales Revenue (Million USD) of Bayer 2017-2020e
66.Figure Cox-2 Inhibitors Sales Revenue (Million USD) of Novartis 2017-2020e
67.Figure Cox-2 Inhibitors Sales Revenue (Million USD) of Pfizer 2017-2020e
68.Figure Cox-2 Inhibitors Sales Revenue (Million USD) of Merck 2017-2020e
69.Figure Cox-2 Inhibitors Sales Revenue (Million USD) of Cadila Pharmaceuticals 2017-2020e
70.Figure Cox-2 Inhibitors Sales Revenue (Million USD) of Sabinsa Corporation 2017-2020e
71.
